ClearBridge Investments’s VanEck Biotech ETF BBH Stock Holding History

ClearBridge Investments’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,850	Closed	-$388K	–	1130
2018 Q3	$388K	Sell	2,850 -4,150	-59%	-$540K	﹤0.01%	771
2018 Q2	$840K	Hold	7,000	–	–	﹤0.01%	658
2018 Q1	$842K	Hold	7,000	–	–	﹤0.01%	643
2017 Q4	$872K	Hold	7,000	–	–	﹤0.01%	651
2017 Q3	$939K	Sell	7,000 -25	-0.4%	-$3.26K	﹤0.01%	635
2017 Q2	$883K	Sell	7,025 -50	-0.7%	-$6.03K	﹤0.01%	638
2017 Q1	$842K	Buy	7,075 +675	+11%	+$78.9K	﹤0.01%	687
2016 Q4	$688K	Buy	6,400 +3,075	+92%	+$334K	﹤0.01%	701
2016 Q3	$383K	Buy	+3,325	New	+$379K	﹤0.01%	727

Other funds holding BBH

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

MCM

Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

SFS

Strategic Financial Services Utica, New York $2.1B AUM 19.14% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MJRIC

Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

ClearBridge Investments's BBH Position: Q4 2018 in Review

ClearBridge Investments sold out of VanEck Biotech ETF (BBH) in Q4 2018, closing a stake of 2,850 shares — an estimated $388K sold.

ClearBridge Investments first reported a position in BBH in Q3 2016 and held it in 9 quarters. The position peaked at $939K in Q3 2017. 84 funds tracked by Wall St. Rank hold BBH as of Q4 2018.

ClearBridge Investments reported no remaining VanEck Biotech ETF position as of Q4 2018 after selling out during the quarter.
ClearBridge Investments sold 2,850 VanEck Biotech ETF shares in Q4 2018, an estimated $388K.
ClearBridge Investments first reported a position in VanEck Biotech ETF in Q3 2016 and held it in 9 quarters.
ClearBridge Investments's VanEck Biotech ETF position peaked at $939K in Q3 2017.
84 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2018.

Based on ClearBridge Investments's 13F filing for Q4 2018, filed 14 Feb 2019.